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Abstract 
 
OBJECTIVE:  With the introduction of diabetes disease management programs (DMP) in 
Germany there is a necessity to evaluate whether patients receive care which is congruent to 
the chronic care model (CCM) and evidence-based behavioural counselling. We examined 
differences as perceived and experienced by patients with type 2 diabetes between those 
enrolled in a DMP compared to patients receiving usual care in two federal states of 
Germany.    
 
RESEARCH DESIGN AND METHODS: A random, heterogeneous sample of 3.546 
patients (59.3% female) received a mailed questionnaire from their regional health fund 
including the German version of the PACIC-5A instrument. Two weeks later a general 
reminder was sent out.  
 
RESULTS: 1.532 questionnaires were returned (response rate 42.2%), valid data could be 
obtained for 1.399 patients. Mean age of responders was 70.3 years of which 53.6% were 
female. Overall, patients enrolled in a DMP scored significantly higher (3.21 of a possible 5) 
than patients not enrolled in a DMP (2.86; p< 0.001). Significant differences in the same 
direction were found on all five subscales of the PACIC. For the 5A scales similar  
differences were found for all 5 subscales plus the sumscore (p<0.001; mean for DMP=3.08, 
mean for non-DMP=2.78).   
 
CONCLUSIONS: DMPs as currently established in primary care in Germany may impact 
provided care significantly. The changes in daily practice which have been induced by the 
DMPs are recognized by patients as care that is more structured and that reflects the core 
elements of the CCM and evidence-based counselling to a larger extent as usual care.  
 
 
 
 
 
Abbreviations : CCM, chronic care model; DMP, disease management program ; PACIC-5A, 
Patient Assessment of Chronic Illness Care including 5A scoring; AOK, regional statutory 
health fund 
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Improving the quality of care for patients with type 2 diabetes and other chronic conditions is 
an important aim of health policy and providers in many countries throughout the world. In 
countries like the US, disease management programs (DMP) – defined as structured, 
multifaceted, systematic approaches to provide better care (1) have been introduced by a vast 
number of  `players´ and providers with different approaches for more than twenty years (2), 
showing small to modest results.  
 
In Germany with its statutory health insurance system, insuring approx. 90% of the 
population, disease management programs were introduced nationwide in 2003 on the basis of 
a new legislation  which aimed to improve the quality of care and to foster competition 
between health insurances (3,4). In contrast to the US the core content of a DMP in Germany 
(e.g. evidence-based clinical guidelines, basic data set, quality indicators, transfer between 
different levels of care, provision of feedback, re-call for patients etc.) is defined by a national 
expert group and its recommendations are compulsory for contracts between insurers and 
providers, although there are smaller differences in detail (e.g. type of feedback-report, 
remuneration etc.) between programs of different contracting partners. Family practitioners 
(general practitioners, family physicians, and internists in private practice) have a central role 
in co-ordinating care of enrolled patients.  
 
At the time of their development and introduction the national DMPs were heavily opposed 
by the medical profession (5, 6) under arguments such as being ´cookbook medicine´, 
providing `suboptimal care´ or that recommendations which were given are not new but are 
already fully implemented into routine daily practice (7). The DMP for type-2 diabetes was 
first introduced in 2003.  By the mid of 2007 about 2.3 million patients with type-2 diabetes 
(approx. 50% of the estimated number of patients in the population) and 30.300 family 
practices (approx. 65%) are actively enrolled (8). Still a reasonable number of physicians 
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refuse to take part. Enrolment of a patient for the programme requires prior enrolment of the 
family physicians of the practice. If the doctors refuse to do that, patients have to change to 
another practice if they want to participate in the DMP. This might be a major barrier for the 
majority of elderly patients with chronic diseases such as diabetes for whom continuity of 
care plays an important role (9). Assuming that the rationales of the programmes (e.g. 
evidence-based, structured care, focussed on patient activation) are not questionable and 
favour better outcomes, it should be expected that family physicians who do not participate in 
the programme provide lower quality of care for their patients than those who are enrolled.      
 
Unfortunately the statutory nationwide evaluation of the DMP for type-2 diabetes does not 
compare providers or patients which are enrolled with those which are not (10). Because of 
the short timeframe in which it was introduced, baseline measurements were not taken. 
Fortunately in two areas of Germany in a larger study (ELSID- Diabetes study-evaluation of a 
large scale implementation of disease management programmes for patients with type 2 
diabetes (11) a cross sectional approach with a cluster RCT intervention to optimize the 
implementation of the DMP is combined. This allows a more systematic comparison of 
patients and practices not enrolled or enrolled on the basis of clinical data, sick-fund claims 
data and patient experiences.  
 
In the meanwhile more comprehensive frameworks such as the Chronic Care Model (CCM)  
receive widespread attention (12, 13) and it is currently evaluated which elements of this 
model may be most effective in improving care processes, costs and clinical outcomes (14, 
15). The Patient Assessment of Chronic Illness Care (PACIC) instrument has been proven to 
be a reliable and valid tool (16)  to measure quality of care according to the CCM and patient 
motivation according to the “5 A” principles with the PACIC-5A regarding different chronic 
diseases as diabetes (17, 18) or arthritis (19, 20). It addresses from a patient’s perspective and 
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experience to what extent provided care complies with the CCM. Since the aim of the DMPs 
is to structure care according to core elements similar to those of the CCM, we hypothesized 
that enrolled patients would achieve higher scores on the PACIC, suggesting better quality of 
care.  
 
RESEARCH DESIGN AND METHODS 
 
For this study we draw a random sample of 3.546 patients (59.3% female) out of the total 
sample (n=20.625, 59.2% female) of the ELSID-study which is performed in two different 
German federal states, Rheinland-Pfalz and Sachsen-Anhalt. The study protocol for the 
ELSID-study and the inclusion criteria for patients were registered and published before (11). 
The protocol for the ELSID-study and for this survey were both fully approved by the ethics 
committee of the University of Heidelberg Medical Faculty.  
 
In November 2006 all 3.546 patients received a mail with a cover letter directly from their 
health insurance (all patients where insured of the statutory regional health care funds, 
Allgemeine Ortskrankenkasse=AOK), including the questionnaire material labelled with a   
unique pseudonym for each patient and a postage-paid return envelope addressed to the study 
centre. Two weeks later all patients received a general reminding letter (without 
questionnaire) from the AOK again, regardless if they had sent their questionnaire back in the 
meanwhile or not. All patients could participate in the draw of a prize of 4 x € 250 (approx. 
USD 375) by sending in a separate postage-paid return envelope to the study centre. The 
questionnaire included sociodemographic data, some self reported health information (weight, 
height, smoking status, a list of chronic conditions in the patients words and the validated and 
culturally adapted German version of the PACIC-5A. This version contained 26 items,  
including 6 items to produce subscales for behavioural counselling according to the U.S. 
Preventive Taskforce recommendations (17). The questions request the patient to evaluate the 
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care they received from their family practitioner over the last 6 months with regard to several 
topics. The answers were given on a five-point Likert scale from 1 = almost never to 5 = 
almost always. After analysis the PACIC-5A supplies a five-scale profile of scores related to 
different aspects of providing care according to the CCM: patient activation, delivery 
system/practice design, goal setting/tailoring, problem solving/contextual, and follow-
up/coordination. Additionally a sum-score can be generated. Another scoring option provides 
five items on each of the 5As subscales of assess, advise, agree, assist and arrange. All single 
items and the structure of the scores for the original source version in English language and 
the culturally adapted and validated German version are described elsewhere (18, 19). 
 
All statistical analyses were conducted with SPSS, version 15.0. Comparisons between groups 
were performed with the Mann-Witney-Test for not normally distributed data and the chi 
square test respectively. The level of significance was p=.05. 
 
RESULTS 
Respondent characteristics 
1.532 questionnaires were returned (response rate 42.2%), valid data could be obtained for 
1.399 patients. Fig. 1 shows a flowchart for the conduct of the study and the response. For 
certain characteristics a non-responder analysis could be performed on the basis of claims 
data. On average responders were younger than non-responders (responder: 70.3 years [95% 
Confidence Interval (CI) 69.9; 70.7], non-responder 71.8 years [71.4; 72.2]), p<0.001. Of the 
responders 649 were male (46.4%) and 750 were female (53.6%) and of the non-responders 
733 were male (35.4%) and 1337 (64.6%) were female. 
 
Various characteristics of the study sample (separated in patients being enrolled in DMP 
(DMP) and patients not enrolled (Non-DMP) are shown in Table 1. Of the 1.399 included 
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patients 649 were male (46.4%) and 750 were female (53.6%). The mean age for the entire 
sample was 70.3 years (SD 8.5). There were no significant differences for other 
sociodemographic characteristics such as being married/living in partnership, lower education 
and low to medium annual household income. The average number of other (comorbid) self-
reported medical conditions (including hypertension, coronary heart disease, chronic heart 
failure, ulcer, asthma, bronchitis, cancer, osteoarthritis and stroke) was 2.1 (minimum 0, 
maximum 8) within the total sample (Table 1). In average the patients were enrolled since 
26.8 months (SD 9.0) into the DMP for type 2 diabetes.     
  
PACIC scale 
The average overall score on the PACIC items was 3.21 of a possible 5 for the patients 
enrolled in the DMP versus 2.86 for the non-DMP patients, under the care of family 
practitioners not enrolled into the DMP. This difference was statistically significant (p< 
0.001), see Table 2. Differences in the same direction were found on all five subscales of the 
PACIC on the same level of significance, except for patient activation where p was < 0.05. 
Nominally the difference was greatest at the follow-up coordination scale (mean difference = 
0.44) and lowest at the patient activation scale (mean difference = 0.17). 
  
5As scoring 
For the 5A scales again significant differences were found for all 5 subscales plus the sum-
score  (p<0.001) (Table 2). The mean for the overall 5A summary scale was 3.08 out of a 
possible 5 for the DMP patients versus a mean of 2.78 for the non-DMP patients. The highest 
mean differences were found for the `assist´ subscale (mean difference = 0.39) and the lowest 
for the `agree´ subscale (mean difference = 0.25). 
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CONCLUSIONS 
 
Patients with type-2 diabetes enrolled in a disease management program were more likely to 
receive patient-centred, structured and collaborative care according to the CCM. This large 
cross sectional study demonstrates significant differences in the quality of care as assessed by 
the PACIC-5A instrument between patients enrolled in the national DMP and patients which 
are not enrolled. These differences were largest for follow-up/coordination of care, goal 
setting/tailoring and for the problem solving/contextual scale. Similar findings were made for 
the 5As subscales where the largest differences in the same direction were found for `assist´, 
`advice´, and `assess´.  
Compared to data for diabetic patients from an US study (18) German patients not 
participating in a DMP fall short in receiving aspects of care on the sum-score and all 
subscales of the PACIC and the 5As subscales. For example on the overall PACIC score the 
patients scored 2.7 versus 3.2 in the US study. In the US study patients scored in average 3.6 
for `patient activation` (our study: 3.1), 3.5 for `delivery system/practice design´ (our study: 
3.3), 3.0 for `goal setting/tailoring` (our study: 2.5), 2.9 for `follow up/coordination´ (our 
study: 2.7), 3.4 for `problem solving/contextual´ (our study: 3.0). This may be due to the 
higher age (our patients were in average 6.3 years older) and the higher number of co morbid 
conditions in our sample and to the fact that our patients in the non-DMP group received care 
in “routine” practices versus selected practices in the sample Glasgow et al draw for their 
validation study. Nevertheless patients enrolled into DMP receive better care as in the US 
study measured on the subscales for follow-up/coordination and similar care on all other 
subscales, including the 5As. In a different study with arthritis patients in Germany we found 
even lower scores for patients at similar age in the control arm (20). This finding might be 
interpreted as some external validation since care for patients with arthritis appears to be less 
structured because of the lack of clear recommendations for management in primary care than 
for diabetes and therefore lower scores on the PACIC-5A can be expected.  
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Our results have to be interpreted carefully. The return rate was modest, but a non-responder 
analysis could be performed, showing that non-responders were slightly older and showed a 
higher proportion of female patients. Our analysis is cross-sectional, with patients from one 
major type of regional health fund, with a market share of more than 40% and a higher 
proportion of elderly insurants with chronic conditions than other insurers. Differences 
between the two groups of patients under investigation exist, but do not allow any conclusion 
about a causal influence of the DMP. This may limit generalisability. 
 
Strengths include the large and heterogeneous sample and the limitation of sampling bias 
within the patients of the health fund by means of clear selection criteria based on existing 
routine claims data and the draw of a random sample out of a very large representative sample 
of more than 20.000 patients with type-2 diabetes. Additionally, patients were not specifically 
informed that the aim of the study was to evaluate a DMP (which may had distorted results as 
DMPs are still under political or public debate from time to time), but to evaluate the actual 
care they receive by the doctor they consider as ´their´ family practitioner.  
 
In conclusion our results suggest that DMPs for diabetes as currently established in primary 
care in Germany may impact provided care significantly. The changes in daily practice which 
have been induced by the DMPs are recognized by patients as care that is more structured and 
that reflects the core elements of the CCM to a larger extent as usual care. In the perception of 
patients these differences exist and they may very well matter in terms of influencing clinical 
and economic outcomes (15). What makes this finding particularly interesting is that prior 
studies, evaluating the implementation of CCM elements, assessed provider structures or 
addressed process parameters. To our knowledge this is the first larger study assessing 
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different types of care (DMP vs. Non-DMP) and accordance of care with the CCM from a 
patients’ perspective with the PACIC-5A instrument.  
 
Our findings have to be completed later by the results of the final evaluation of the ELSID 
study. Of course it will be important to see if clinical parameters will improve in the DMP 
group. Nevertheless, these results might yield additional insight to the ongoing discussion on 
effective improvements of the quality of care for patients with chronic conditions.    
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Table 1: Patient characteristics 
 
 DMP 
(n=865) 
Non-DMP 
(n=534) 
p-value  
Age (years)  70.2 (8.3) 70.5 (8.9) 0.52 
Women 465 (53.8) 285 (53.4) 0.89 
BMI 30.3 (5.8) 30.3 (6.5) 0.86 
Smokers 68 (8.0) 49 (9.3) 0.39 
Number of other 
chronic conditions
2.1 (1.3) 2.1 (2.1) 0.51 
≤ 9 years of  
Education  
612 (70.8) 386 (72.3) 0.54 
Annual household 
income  
≤ 21.000 € 
722 (83.5) 435 (81.5) 0.34 
Married / Living in 
partnership 
568 (65.7) 336 (62.9) 0.51 
All Data were mean (SD) or number (percentage) 
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Table 2: Results for overall PACIC scale, 5A scoring overall scale and all 
subscales, differences between DMP and Non-DMP patients 
 
Scale DMP 95% CI Non-
DMP 
95% CI Significances 
of differences 
(p-values) 
Overall PACIC 
score 
3.26 (0.9) 3.14; 3.27 2.86 (0.9) 2.78;2.94 <0.001 
Patient 
activation 
3.26 (1.2) 3.18;3.34 3.09 (1.2) 2.98;3.19 <0,05 
Delivery 
system / 
practice 
design 
3.52 (0.9) 3.46;3.58 3.29 (0.9) 3.21;3.37 <0.001 
Goal setting / 
tailoring 
2.91 (1.1) 2.83; 2.98 2.50 (1.1) 2.40; 2.59 <0.001 
Follow-up / 
coordination 
3.13 (1.1) 3.06; 3.21 2.70 (1.1) 2.60;2.79 <0.001 
Problem 
solving / 
contextual 
3.39 (1.2) 3.31;3.47 3.04 (1.2) 2.93;3.14 <0.001 
      
Overall 5A 
score 
3.08 (1.0) 3.02;3.15 2.78 (1.0) 2.70; 2.86 <0.001 
Assess 3.26 (1.1) 3.18;3.33 2.91 (1.1) 2.81;3.00 <0.001 
Agree 3.24 (1.1) 3.17;3.32 2.99 (1.1) 2.89;3.09 <0.001 
Advise 3.32 (0.9) 3.25;3.38 2.95 (1.0) 2.86;3.04 <0.001 
Assist 3.21 (1.1) 3.13;3.28 2.82 (1.1) 2.72;2.91 <0.001 
Arrange 2.87 (1.0) 2.80;2.93 2.55 (1.0) 2.46;2.64 <0.001 
All data were mean (SD) or CI 
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Figure 1  Flowchart response  
 
 
 
 
 
 
 
 
 
 
 
 Random sample for the survey: 
3546 patients with type 2 
diabetes 
No response 
 
2014 (56.8%)
Response: 1532  
questionnaires (43.2%) 
Excluded: 133 
(3.8%)   
 
- 58: not filled in 
- 74: no type 2  
        diabetes (self 
        reported)  
Analysed: 1399  
Total sample observed in the  
ELSID-Study: 20625 patients  
with type 2 diabetes 
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